Mfn2 deletion in these neurons prevents these adverse metabolic effects: fat mass was reduced, insulin and glucose levels were legitimized, and obesity was avoided (Dietrich et al., 2013). This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.